Form 4 for CGNX COGNEX CORP
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001938568-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-19 | 2026-02-18 | CGNX | Kuechen Joerg | CTO | F - Tax | $56.72 | -1,327 | 2,729 | -33% | -$75.3K |
| D | 2026-02-19 | 2026-02-18 | CGNX | Kuechen Joerg | CTO | M - OptEx | $0.00 | +4,056 | 4,056 | New | $0 |
| D | 2026-02-19 | 2026-02-17 | CGNX | Kuechen Joerg | CTO | A - Grant | $0.00 | +8,759 | 8,759 | New | $0 |
| D | 2026-02-19 | 2026-02-18 | CGNX | Kuechen Joerg | CTO | M - OptEx | $0.00 | -4,056 | 16.2K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | F | D | 1,327 | $56.72 | 2,729 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-18 | M | A | 4,056 | $0.00 | 4,056 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-17 | A | A | 8,759 | $0.00 | 8,759 | D | $0.00 · 2028-02-17 to 2028-02-17 | 8,759 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. (F3) The restricted stock units vest 100% on the second anniversary of the grant date (February 17, 2026). |
| 4 | Derivative | Restricted Stock Unit | 2026-02-18 | M | D | 4,056 | $0.00 | 16,223 | D | $0.00 · 2026-02-18 to 2028-02-18 | 4,056 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. (F4) The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively. |